Table 2.

Demographic characteristics of successful PD by stent type

Variable	SEMS n=71	PES n=149	NS n=289	p-value	SEMS vs PES p-value
N (%) or Median (range)
Gender: Female	36 (50.7%)	64 (43.0%)	140 (48.4%)	0.447	0.312
Age	67 (38-89)	68 (39-92)	65 (19-88)	0.038	0.858
ASA class 3 or 4	48 (67.6%)	76 (51.4%)	164 (57.1%)	0.073	0.029
Pathology: Adenocarcinoma	67 (94.4%)	135 (90.6%)	145 (50.2%)	<0.001	0.436
Neoadjuvant Therapy*	23 (34.3%)	10 (7.4%)	14 (9.7%)	<0.001	<0.001

ASA, American Society of Anesthesiologist Physical Status Classification System

^*Neoadjuvant therapy rates were summarized and compared in the subset of patients with adenocarcinoma